Table 1 Demographics, respiratory co-morbidities and corticosteroid usage in NTM patients
| Â | Patients with MAI complex NTM | Patients with NTM only other than MAI | Â |
|---|---|---|---|
Total Subjects | 36 | 38 | Â |
Mean Age/yrs (standard error of mean; range) | 63.3 (2.74; 22.6 – 88.7) | 64.4 (2.49; 31.3 – 90.3) | p = 0.78 |
Sex | 22 female, 14 male | 17 female, 21 male | p = 0.16 |
Subjects culturing multiple NTM species | 18 (50%) | 8 (21%) | p = 0.009 |
Asthma | 6 (17%) | 4 (11%) | p = 0.44 |
COPD | 9 (25%) | 15 (39%) | p = 0.18 |
Bronchiectasis | 15 (42%) | 5 (13%) | p = 0.006 |
ABPA | 1 (3%) | 0 (0%) | p = 0.30 |
Nasal Polyps | 2 (6%) | 1 (3%) | p = 0.52 |
on Inhaled Corticosteroids | 19 (53%) | 15 (39%) | p = 0.25 |
on Oral Corticosteroids | 3 (8%) | 3 (8%) | p = 0.94 |